Cheil Bio Co Ltd
KOSDAQ:052670
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cheil Bio Co Ltd
Change in Working Capital
Cheil Bio Co Ltd
Change in Working Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Change in Working Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Cheil Bio Co Ltd
KOSDAQ:052670
|
Change in Working Capital
₩205.4m
|
CAGR 3-Years
131%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Change in Working Capital
-₩109B
|
CAGR 3-Years
-38%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-23%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Change in Working Capital
-₩55.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Change in Working Capital
-₩212.2B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-2%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Change in Working Capital
-₩17B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-6%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Change in Working Capital
-₩21.9B
|
CAGR 3-Years
32%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Cheil Bio Co Ltd
Glance View
Cheil Bio Co., Ltd. engages in the manufacture and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company is headquartered in Ansan, Gyeonggi-Do and currently employs 43 full-time employees. The company went IPO on 2002-01-24. The firm's offerings consist of antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, diagnostic kits including enzyme-linked immunosorbent assay (ELISA) test kits, virus test kits and deoxyribonucleic acid (DNA) kits, as well as feed additives. The Company’s products are used for cattle, pigs, chickens, pets and other animals. The company supplies its products mainly to the domestic market.
See Also
What is Cheil Bio Co Ltd's Change in Working Capital?
Change in Working Capital
205.4m
KRW
Based on the financial report for Sep 30, 2025, Cheil Bio Co Ltd's Change in Working Capital amounts to 205.4m KRW.
What is Cheil Bio Co Ltd's Change in Working Capital growth rate?
Change in Working Capital CAGR 5Y
-33%
The average annual Change in Working Capital growth rates for Cheil Bio Co Ltd have been 131% over the past three years , -33% over the past five years .
